CoChat

Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus

Open access

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Contrary to prior case reports that described occasional clinical failures with cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infections, recent studies have demonstrated no difference in outcomes between cefazolin and antistaphylococcal penicillins for the treatment of MSSA bacteremia. While promising, these studies described low frequencies of high-inoculum infections, such as endocarditis. This retrospective study compares clinical outcomes of cefazolin versus oxacillin for complicated MSSA bacteremia at two tertiary care hospitals between January 2008 and June 2012. Fifty-nine patients treated with cefazolin and 34 patients treated with oxacillin were included. Osteoarticular (41%) and endovascular (20%) sources were the predominant sites of infection. The rates of clinical cure at the end of therapy were similar between cefazolin and oxacillin (95% versus 88%; P = 0.25), but overall failure at 90 days was higher in the oxacillin arm (47% versus 24%; P = 0.04). Failures were more likely to have received surgical interventions (63% versus 40%; P = 0.05) and to have an osteoarticular source (57% versus 33%; P = 0.04). Failures also had a longer duration of bacteremia (7 versus 3 days; P = 0.0002), which was the only predictor of failure. Antibiotic selection was not predictive of failure. Rates of adverse drug events were higher in the oxacillin arm (30% versus 3%; P = 0.0006), and oxacillin was more frequently discontinued due to adverse drug events (21% versus 3%; P = 0.01). Cefazolin appears similar to oxacillin for the treatment of complicated MSSA bacteremia but with significantly improved safety. The higher rates of failure with oxacillin may have been confounded by other patient factors and warrant further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.02800-14

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 6

  1. EchevarriaKChildsLOatesECadenaJ. 2012. Antibiotic stewardship involving anti-staphylococcal beta-lactams at a Veterans Affairs hospital. Abstr. IDWeek 2012, abstr 34750.
  2. LewisJSIIBowlingJELaurelYJorgensenJH. 2012. Clinical and financial impact of the replacement of oxacillin with cefazolin for MSSA infections. Abstr. IDWeek 2012, abstr 739.
  3. NevrekarSRhodesNCrankCScheetzMHPavellASegretiJWangS. 2013. Treatment outcomes of cefazolin versus oxacillin for high burden methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections (BSI). Abstr. IDWeek 2013, abstr 1731.
  4. HuangMKnepperBHaasMJenkinsT. 2013. Effects of an intervention to substitute cefazolin for nafcillin in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia. Abstr. IDWeek 2013, abstr 1017.
  5. NuibeAOlsonJHershAStockmannCSandersonSPaviaAThorellEA. 2013. Costs and outcomes for children with methicillin-susceptible Staphylococcus aureus osteoarticular infections with bacteremia. Abstr. IDWeek 2013, abstr 421.
  6. LeeSKwonKTKimHIChangHHLeeJMChoePGParkWBKimNJOhMDKimSW. 2013. Clinical implication of cefazolin inoculum effect on methicillin-susceptible Staphylococcus aureus bacteremia. Abstr. IDWeek 2013, abstr 375.

Cited by

See all 120

Metadata

Authors
Li, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Venue
Antimicrobial Agents and Chemotherapy
Published
2014-09
Volume
58
Issue
9
Pages
5117-5124
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2168149280
Cited by
117
References
25
Citations by year
2026: 5 · 2025: 11 · 2024: 3 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 10 · 2019: 10 · 2018: 23 · 2017: 13 · 2016: 10 · 2015: 6 · 2014: 1
FWCI
7.03
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Texas ScholarWorks (Texas Digital Library) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
cefazolin, oxacillin, methicillin-susceptible Staphylococcus aureus, complicated bacteremia, antibiotic treatment failure, adverse drug reactions, bone and joint infections, endovascular infection, duration of bacteremia, surgical treatment, antibiotic selection
MeSH terms
Anti-Bacterial Agents, Cefazolin, Female, Humans, Male, Methicillin, Microbial Sensitivity Tests, Middle Aged, Oxacillin, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Bacteremia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus. https://app.cochat.ai/papers/10.1128/aac.02800-14
The paper
Li, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S. (2014). Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.02800-14

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.